Anhui Anke Biotechnology (Group) Co., Ltd. (SHE: 300009)

Anhui Anke Biotechnology (Group) Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	14,181	17,094	15,623	21,448	20,044	15,849
Market Cap Growth	-1.02%	9.42%	-27.16%	7.00%	26.47%	18.95%
Enterprise Value	13,162	16,089	14,822	20,627	19,445	15,561
Last Close Price	8.50	9.96	8.90	12.18	11.27	8.85
PE Ratio	18.10	20.18	22.21	103.80	55.84	127.34
Forward PE	-	17.47	21.27	35.62	43.82	36.81
PS Ratio	5.12	5.97	6.70	9.89	11.78	9.25
PB Ratio	3.73	4.35	4.59	7.39	6.84	5.87
P/TBV Ratio	4.77	5.31	5.43	8.24	8.58	7.50
P/FCF Ratio	23.80	22.56	69.55	46.53	61.43	145.21
P/OCF Ratio	21.97	17.94	22.35	36.22	43.12	53.61
EV/Sales Ratio	4.76	5.61	6.36	9.51	11.43	9.09
EV/EBITDA Ratio	14.18	15.99	17.73	30.48	42.03	33.69
EV/EBIT Ratio	16.10	17.62	19.61	34.42	49.02	38.95
EV/FCF Ratio	22.09	21.24	65.98	44.75	59.60	142.56
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.00	0.01
Debt / EBITDA Ratio	0.06	0.06	0.04	0.04	0.03	0.06
Debt / FCF Ratio	0.09	0.07	0.15	0.06	0.04	0.26
Asset Turnover	0.58	0.62	0.59	0.60	0.51	0.60
Inventory Turnover	2.28	2.83	2.62	2.59	2.61	3.44
Quick Ratio	2.66	2.43	2.45	2.74	3.10	3.21
Current Ratio	3.20	2.75	2.83	3.07	3.47	3.56
Return on Equity (ROE)	20.21%	23.41%	23.40%	6.97%	12.31%	4.69%
Return on Assets (ROA)	10.67%	12.39%	11.92%	10.44%	7.37%	8.68%
Return on Capital (ROIC)	12.86%	15.37%	14.84%	12.75%	8.74%	10.32%
Earnings Yield	5.52%	4.96%	4.50%	0.96%	1.79%	0.79%
FCF Yield	4.20%	4.43%	1.44%	2.15%	1.63%	0.69%
Dividend Yield	2.99%	2.51%	2.81%	1.64%	1.48%	1.09%
Payout Ratio	52.83%	48.52%	46.58%	132.37%	44.35%	130.01%
Buyback Yield / Dilution	-0.64%	-1.57%	-2.90%	2.58%	1.68%	-5.12%
Total Shareholder Return	2.35%	0.94%	-0.09%	4.23%	3.16%	-4.03%

Source: S&P Capital IQ. Standard template. Financial Sources.